ShockWave Medical, Inc. (SWAV) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Santa Clara, CA, アメリカ. 現CEOは Douglas E. Godshall.
SWAV を有する IPO日 2019-03-07, 1,468 名の正社員, に上場 NASDAQ Global Select, 時価総額 $12.57B.
ShockWave Medical, Inc. is a medical device company that develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases globally. The company's product portfolio includes M5 catheters for above-the-knee peripheral artery disease, C2 catheters for coronary artery disease, and S4 catheters for below-the-knee peripheral artery disease. ShockWave Medical serves interventional cardiologists, vascular surgeons, and interventional radiologists through a network of sales representatives, managers, and distributors. Founded in 2009 and headquartered in Santa Clara, California, the company addresses critical treatment needs across multiple vascular intervention markets.
